VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $423,000 | -19.7% | 2,374 | 0.0% | 0.09% | -12.4% |
| Q2 2015 | $527,000 | +11.7% | 2,374 | 0.0% | 0.10% | +14.1% |
| Q1 2015 | $472,000 | +38.8% | 2,374 | 0.0% | 0.09% | +43.8% |
| Q4 2014 | $340,000 | -9.8% | 2,374 | -17.4% | 0.06% | -12.3% |
| Q3 2014 | $377,000 | +4.1% | 2,874 | 0.0% | 0.07% | +5.8% |
| Q2 2014 | $362,000 | -4.5% | 2,874 | 0.0% | 0.07% | -9.2% |
| Q1 2014 | $379,000 | +12.5% | 2,874 | 0.0% | 0.08% | +10.1% |
| Q4 2013 | $337,000 | +12.3% | 2,874 | 0.0% | 0.07% | +3.0% |
| Q3 2013 | $300,000 | +21.5% | 2,874 | 0.0% | 0.07% | +31.4% |
| Q2 2013 | $247,000 | – | 2,874 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |